nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—OPRD1—Signaling Pathways—E2F3—ocular cancer	0.000425	0.000425	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000422	0.000422	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000422	0.000422	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—AKT1—ocular cancer	0.000421	0.000421	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000421	0.000421	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00042	0.00042	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—HRAS—ocular cancer	0.000419	0.000419	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—GNAQ—ocular cancer	0.000416	0.000416	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PSPH—ocular cancer	0.000415	0.000415	CbGpPWpGaD
Naloxone—ALB—Metabolism—PSPH—ocular cancer	0.000412	0.000412	CbGpPWpGaD
Naloxone—CREB1—Downstream signal transduction—AKT1—ocular cancer	0.000408	0.000408	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—TGFB1—ocular cancer	0.000407	0.000407	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR—AKT1—ocular cancer	0.000406	0.000406	CbGpPWpGaD
Naloxone—CREB1—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000406	0.000406	CbGpPWpGaD
Naloxone—TLR4—Immune System—EP300—ocular cancer	0.000406	0.000406	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.000406	0.000406	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—GNA11—ocular cancer	0.000406	0.000406	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000406	0.000406	CbGpPWpGaD
Naloxone—CREB1—Circadian rythm related genes—TP53—ocular cancer	0.000405	0.000405	CbGpPWpGaD
Naloxone—CREB1—Signaling by ERBB2—AKT1—ocular cancer	0.000404	0.000404	CbGpPWpGaD
Naloxone—CREB1—DAP12 signaling—AKT1—ocular cancer	0.000403	0.000403	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—TFDP1—ocular cancer	0.000399	0.000399	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—HRAS—ocular cancer	0.000397	0.000397	CbGpPWpGaD
Naloxone—CREB1—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000397	0.000397	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TFDP1—ocular cancer	0.000396	0.000396	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TFDP1—ocular cancer	0.000395	0.000395	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—TP53—ocular cancer	0.00039	0.00039	CbGpPWpGaD
Naloxone—CREB1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000389	0.000389	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.000387	0.000387	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000386	0.000386	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.00038	0.00038	CbGpPWpGaD
Naloxone—CREB1—DAP12 interactions—AKT1—ocular cancer	0.000379	0.000379	CbGpPWpGaD
Naloxone—CREB1—Signaling by FGFR in disease—AKT1—ocular cancer	0.000379	0.000379	CbGpPWpGaD
Naloxone—CREB1—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000379	0.000379	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SAG—ocular cancer	0.000378	0.000378	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—GNA11—ocular cancer	0.000378	0.000378	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—E2F5—ocular cancer	0.000378	0.000378	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—GNAQ—ocular cancer	0.000377	0.000377	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR—AKT1—ocular cancer	0.000375	0.000375	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—E2F3—ocular cancer	0.000372	0.000372	CbGpPWpGaD
Naloxone—CREB1—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000372	0.000372	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—AKT1—ocular cancer	0.00037	0.00037	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—E2F4—ocular cancer	0.00037	0.00037	CbGpPWpGaD
Naloxone—CREB1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000367	0.000367	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000364	0.000364	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RBL1—ocular cancer	0.000363	0.000363	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PSPH—ocular cancer	0.000361	0.000361	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.00036	0.00036	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000356	0.000356	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—GNAQ—ocular cancer	0.000351	0.000351	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—AKT1—ocular cancer	0.00035	0.00035	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TFDP1—ocular cancer	0.000346	0.000346	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000344	0.000344	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—GNA11—ocular cancer	0.000343	0.000343	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000337	0.000337	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000336	0.000336	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000335	0.000335	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—E2F5—ocular cancer	0.000335	0.000335	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000334	0.000334	CbGpPWpGaD
Naloxone—CREB1—Disease—HDAC1—ocular cancer	0.000328	0.000328	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—E2F4—ocular cancer	0.000328	0.000328	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RBL1—ocular cancer	0.000322	0.000322	CbGpPWpGaD
Naloxone—ALB—Hemostasis—GNA11—ocular cancer	0.00032	0.00032	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—GNAQ—ocular cancer	0.000319	0.000319	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—HRAS—ocular cancer	0.000317	0.000317	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MAML2—ocular cancer	0.000317	0.000317	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—E2F3—ocular cancer	0.000315	0.000315	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MAML2—ocular cancer	0.000315	0.000315	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MAML2—ocular cancer	0.000314	0.000314	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—MDM2—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Naloxone—CREB1—Neuronal System—HRAS—ocular cancer	0.000298	0.000298	CbGpPWpGaD
Naloxone—ALB—Hemostasis—GNAQ—ocular cancer	0.000298	0.000298	CbGpPWpGaD
Naloxone—CREB1—Disease—CDKN2B—ocular cancer	0.000294	0.000294	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TFDP1—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—HRAS—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—MDM2—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000289	0.000289	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000282	0.000282	CbGpPWpGaD
Naloxone—ESR1—Signaling by ERBB4—AKT1—ocular cancer	0.00028	0.00028	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—E2F3—ocular cancer	0.000279	0.000279	CbGpPWpGaD
Naloxone—TLR4—Immune System—HRAS—ocular cancer	0.000278	0.000278	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CDKN1B—ocular cancer	0.000277	0.000277	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—EP300—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MAML2—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—GNA11—ocular cancer	0.000274	0.000274	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—GNA11—ocular cancer	0.000274	0.000274	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HDAC1—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CDKN1B—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GNA11—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—HRAS—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TFDP1—ocular cancer	0.000259	0.000259	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—AKT1—ocular cancer	0.000258	0.000258	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CDKN1A—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—GNAQ—ocular cancer	0.000255	0.000255	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000255	0.000255	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—GNAQ—ocular cancer	0.000254	0.000254	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—GNAQ—ocular cancer	0.000247	0.000247	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CDKN1A—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Naloxone—TLR4—Immune System—AKT1—ocular cancer	0.000245	0.000245	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—EP300—ocular cancer	0.000243	0.000243	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—GNA11—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—TGFB1—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MAML2—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—HDAC1—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HDAC1—ocular cancer	0.00023	0.00023	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HDAC1—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—GNAQ—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PSPH—ocular cancer	0.000223	0.000223	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000215	0.000215	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—CDKN2B—ocular cancer	0.000208	0.000208	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CDKN2B—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MAML2—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CDKN2B—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GNA11—ocular cancer	0.000203	0.000203	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HDAC1—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000199	0.000199	CbGpPWpGaD
Naloxone—ALB—Hemostasis—CDK2—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—E2F1—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—HRAS—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—E2F1—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GNAQ—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CDKN2B—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GNA11—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Naloxone—CREB1—Immune System—MDM2—ocular cancer	0.000177	0.000177	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HDAC1—ocular cancer	0.00017	0.00017	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—MYC—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GNAQ—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—HRAS—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—AKT1—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—E2F1—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Naloxone—CREB1—Disease—MDM2—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Naloxone—CREB1—Immune System—CDKN1B—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HRAS—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CDKN2B—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HDAC1—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Naloxone—CREB1—Disease—CDKN1B—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Naloxone—CREB1—Immune System—CDKN1A—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—AKT1—ocular cancer	0.000147	0.000147	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000146	0.000146	CbGpPWpGaD
Naloxone—CREB1—Immune System—EP300—ocular cancer	0.000142	0.000142	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—AKT1—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—E2F1—ocular cancer	0.00014	0.00014	CbGpPWpGaD
Naloxone—CREB1—Disease—CDKN1A—ocular cancer	0.000138	0.000138	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CDKN2B—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Naloxone—CREB1—Disease—EP300—ocular cancer	0.000131	0.000131	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GNA11—ocular cancer	0.000131	0.000131	CbGpPWpGaD
Naloxone—ALB—Metabolism—GNA11—ocular cancer	0.00013	0.00013	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000125	0.000125	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—E2F1—ocular cancer	0.000124	0.000124	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000123	0.000123	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—GNAQ—ocular cancer	0.000121	0.000121	CbGpPWpGaD
Naloxone—ALB—Metabolism—GNAQ—ocular cancer	0.000121	0.000121	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MDM2—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Naloxone—CREB1—Disease—MYC—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MDM2—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Naloxone—CREB1—Disease—TGFB1—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GNA11—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Naloxone—ALB—Hemostasis—EP300—ocular cancer	0.000107	0.000107	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—HRAS—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—HRAS—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—GNAQ—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CDKN1B—ocular cancer	0.000104	0.000104	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CDKN1B—ocular cancer	0.000104	0.000104	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—AKT1—ocular cancer	0.000103	0.000103	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MDM2—ocular cancer	9.99e-05	9.99e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCND1—ocular cancer	9.96e-05	9.96e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCND1—ocular cancer	9.93e-05	9.93e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.79e-05	9.79e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.74e-05	9.74e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—HRAS—ocular cancer	9.71e-05	9.71e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CDKN1A—ocular cancer	9.64e-05	9.64e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CDKN1A—ocular cancer	9.6e-05	9.6e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—AKT1—ocular cancer	9.38e-05	9.38e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—AKT1—ocular cancer	9.35e-05	9.35e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TGFB1—ocular cancer	9.3e-05	9.3e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—HRAS—ocular cancer	9.28e-05	9.28e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—EP300—ocular cancer	9.17e-05	9.17e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—EP300—ocular cancer	9.14e-05	9.14e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CDKN1B—ocular cancer	9.13e-05	9.13e-05	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—AKT1—ocular cancer	9.03e-05	9.03e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—HRAS—ocular cancer	8.96e-05	8.96e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—EP300—ocular cancer	8.88e-05	8.88e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCND1—ocular cancer	8.71e-05	8.71e-05	CbGpPWpGaD
Naloxone—CREB1—Immune System—AKT1—ocular cancer	8.57e-05	8.57e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MDM2—ocular cancer	8.45e-05	8.45e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CDKN1A—ocular cancer	8.42e-05	8.42e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—AKT1—ocular cancer	8.2e-05	8.2e-05	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MYC—ocular cancer	8.05e-05	8.05e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—EP300—ocular cancer	8.01e-05	8.01e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MYC—ocular cancer	7.99e-05	7.99e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TGFB1—ocular cancer	7.97e-05	7.97e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MYC—ocular cancer	7.96e-05	7.96e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TGFB1—ocular cancer	7.94e-05	7.94e-05	CbGpPWpGaD
Naloxone—CREB1—Disease—AKT1—ocular cancer	7.91e-05	7.91e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—HRAS—ocular cancer	7.85e-05	7.85e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CDKN1B—ocular cancer	7.71e-05	7.71e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—ocular cancer	7.65e-05	7.65e-05	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—AKT1—ocular cancer	7.63e-05	7.63e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MDM2—ocular cancer	7.49e-05	7.49e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCND1—ocular cancer	7.36e-05	7.36e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—HRAS—ocular cancer	7.32e-05	7.32e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CDKN1A—ocular cancer	7.12e-05	7.12e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GNA11—ocular cancer	7.01e-05	7.01e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MYC—ocular cancer	6.98e-05	6.98e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TGFB1—ocular cancer	6.97e-05	6.97e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—AKT1—ocular cancer	6.93e-05	6.93e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CDKN1B—ocular cancer	6.84e-05	6.84e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—EP300—ocular cancer	6.77e-05	6.77e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—ocular cancer	6.56e-05	6.56e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—ocular cancer	6.54e-05	6.54e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCND1—ocular cancer	6.52e-05	6.52e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—GNAQ—ocular cancer	6.51e-05	6.51e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—AKT1—ocular cancer	6.46e-05	6.46e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CDKN1A—ocular cancer	6.31e-05	6.31e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HRAS—ocular cancer	6.27e-05	6.27e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HRAS—ocular cancer	6.25e-05	6.25e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—EP300—ocular cancer	6.01e-05	6.01e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MYC—ocular cancer	5.9e-05	5.9e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TGFB1—ocular cancer	5.89e-05	5.89e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—ocular cancer	5.73e-05	5.73e-05	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—AKT1—ocular cancer	5.58e-05	5.58e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—AKT1—ocular cancer	5.54e-05	5.54e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—AKT1—ocular cancer	5.52e-05	5.52e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HRAS—ocular cancer	5.48e-05	5.48e-05	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—AKT1—ocular cancer	5.36e-05	5.36e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MYC—ocular cancer	5.23e-05	5.23e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TGFB1—ocular cancer	5.22e-05	5.22e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—ocular cancer	4.85e-05	4.85e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—AKT1—ocular cancer	4.84e-05	4.84e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HRAS—ocular cancer	4.64e-05	4.64e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—EP300—ocular cancer	4.36e-05	4.36e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—EP300—ocular cancer	4.34e-05	4.34e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—ocular cancer	4.3e-05	4.3e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HRAS—ocular cancer	4.11e-05	4.11e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—AKT1—ocular cancer	4.09e-05	4.09e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—EP300—ocular cancer	3.8e-05	3.8e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—AKT1—ocular cancer	3.63e-05	3.63e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—AKT1—ocular cancer	2.64e-05	2.64e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—AKT1—ocular cancer	2.62e-05	2.62e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—EP300—ocular cancer	2.34e-05	2.34e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—AKT1—ocular cancer	2.3e-05	2.3e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—AKT1—ocular cancer	1.41e-05	1.41e-05	CbGpPWpGaD
